Add Company
Join Now

Neurimmune Revenue and Competitors

License our Company Data API

Schlieren,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Neurimmune's estimated annual revenue is currently $17.3M per year.(i)
  • Neurimmune's estimated revenue per employee is $201,000

Employee Data

  • Neurimmune has 86 Employees.(i)
  • Neurimmune grew their employee count by 5% last year.

Neurimmune's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Neurimmune?

Neurimmune is a biopharmaceutical company translating human immune memory into antibody therapeutics. Neurimmune discovered aducanumab for Alzheimer's disease together with a team of researchers at the University of Zurich and licensed it to Biogen. Neurimmune's Reverse Translational Medicine technology platform translates the genetic information from human white blood cells into selective high-affinity antibody drug candidates. Besides aducanumab, Neurimmune discovered cinpanemab for Parkinson's disease, the anti-tau antibody BIIB076 for Alzheimer's disease, the anti-miSOD1 antibody AP-101 for amyotrophic lateral sclerosis, and the anti-ATTR antibody NI006 for cardiomyopathy. These programs are currently evaluated in clinical trials.

keywords:N/A

N/A

Total Funding

86

Number of Employees

$17.3M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18.4M91-3%N/A
#2
N/A946%N/A
#3
$9.8M988%N/A
#4
$33.3M14410%N/A